A synthetic strategy to pyrrolo[2,1-f][1,2,4]triazines is reported. We show that various synthetically easily accessible 1,2,4-triazines can be efficiently alkylated under mild conditions to provide the corresponding 1-alkyl-1,2,4-triazinium salts. These bench-stable salts serve as precursors to triazinium ylides, which react in 1,3-dipolar cycloadditions with electron-poor dipolarophiles to yield polysubstituted pyrrolotriazines in a single step.
A synthetic strategy to pyrrolo[2,1-f][1,2,4]triazines is reported. We show that various synthetically easily accessible 1,2,4-triazines can be efficiently alkylated under mild conditions to provide the corresponding 1-alkyl-1,2,4-triazinium salts. These bench-stable salts serve as precursors to triazinium ylides, which react in 1,3-dipolar cycloadditions with electron-poor dipolarophiles to yield polysubstituted pyrrolotriazines in a single step.
The bridgehead pyrrolo[2,1-f][1,2,4]triazine heterocycle
is a privileged scaffold found in numerous pharmaceutically important
substances. The biological activities of compounds containing the
pyrrolotriazine core include inhibition of kinases, anticancer activities,
and potent antiviral effects.[1−8]The first synthesis of the heterocycle based on addition/fragmentation
of 1,2,4-triazines (hereafter denoted as triazines) with dimethyl
acetylenedicarboxylate (DMAD) was reported by Neuenhoeffer in 1977.[9] Two years later, Migliara and co-workers reported
synthesis of the pyrrolotriazine core via an acid-mediated cyclization
of semicarbazone onto a pendant α-ketoester, followed by a base-promoted
cyclization and decarboxylation.[10] These
pioneering studies paved the way for later re-emergence of the heterocycle
as a ‘purine-like’ scaffold introduced into a series
of C-nucleoside analogues.[11−13] The discovery that C-4-substituted
pyrrolotriazines are potent ATP-competitive kinase inhibitors[14] further fueled the research interest in these
compounds and led to numerous candidates in late stages of clinical
development and to approved drugs (Figure ).[1,7,15−20]
Figure 1
Examples
of biologically active pyrrolo[2,1-f][1,2,4]triazines
(and their respective targets).
Examples
of biologically active pyrrolo[2,1-f][1,2,4]triazines
(and their respective targets).A typical synthetic route leading to pyrrolotriazines follows a
number of steps depicted in Scheme A. Variations in these steps and late-stage modification
of the heterocycle by, for example, cross-coupling reactions can provide
access to diverse derivatives with a wide range of potential biological
activities.[21−23]
Scheme 1
(A) Example of a Typical Synthetic Route to Pyrrolo[2,1-f][1,2,4]triazines. (B) Single-Step Construction of Pyrrolotriazines
via 1,3-Dipolar Cycloadditions
Despite the pharmacological importance of pyrrolotriazines reflected
in numerous literature reports and patent applications, virtually
no alternative synthetic procedures to the scaffold exist. Even the
most recent examples exploit reactions that have been originally developed
decades ago.[24] To the best of our knowledge,
the only alternative route to pyrrolotriazines, briefly examined in
the early 90s, was based on cycloadditions of 1-alkyl-1,2,4-triazinium
ylides generated in situ from the respective triazinium precursors
under basic conditions.[25] Despite its great
synthetic potential, this methodology has remained largely unexplored
and neglected.Herein, we show that various, previously unknown
pyrrolotriazines
can be prepared in a single step from readily accessible 1-alkyl-1,2,4-triazinium
salts via 1,3-dipolar cycloaddition (DCA) of the in situ generated
triazinium ylides with electron-poor dipolarophiles (Scheme B).
Results and Discussion
Substituted 1,2,4-triazines are synthetically readily accessible
heterocycles. Depending on the substitution pattern, their preparation
typically includes a single and usually high-yielding condensation
step starting from various commercial glyoxal hydrates and S-alkyl isothiosemicarbazides in the presence of sodium
bicarbonate. More recent synthetic routes include regioselective reactions
of N-tosyl hydrazones with aziridines,[26] carbene N–H insertion of hydrazides,[27] O–H insertion of rhodium-azavinylcarbenes,[28] Zn-catalyzed hydrohydrazination of propargylamides,[29] cycloaddition of tetrazines,[30] or domino annulation reactions.[31] There are numerous possibilities to further derivatize and decorate
the basic heterocyclic core. For example, simple 3-substituted triazines
are susceptible to an easy nucleophilic attack at position 5 followed
by position 6.[32,33] The S-alkyl
substituents can be utilized in cross-coupling reactions[33,34] or after oxidation, used in nucleophilic substitutions.[35,36] Therefore, the substrate scope of the starting triazines is immense,
opening an easy access to diverse 1-alkyl-1,2,4-triazinium salts.The first goal of our study was to optimize the alkylation of the
triazine core. For this purpose, we used 3-phenyltriazine 1a(34) and the commercial 3-methylthiotriazine
and explored different alkylating agents and reaction conditions (Table S1). These experiments revealed that the
alkylation with benzyl bromide and dimethyl sulfate is sluggish, while
methyl iodide proved unreactive. In contrast, the use of Meerwein’s
salt (Me3O+BF4–) led to clean formation of the N1-alkylated product.[25] Due to difficulties in handling this sensitive
compound, we decided to explore triflates as more convenient alkylating
agents. To our delight, the alkylation with methyl or ethyl triflate
was successful. Interestingly, the simple 3-aryltriazines are alkylated
exclusively at position 1, while electronically richer derivatives,
such as the commercial 3-methylthiotriazine, led under the same conditions
to the formation of products alkylated at both, N1 and N2, as determined by heteronuclear multiple
bond correlation nuclear magnetic resonance (NMR) experiments.The observed differences in the preferred position for the alkylation
can be explained, at least in part, by differences in the electrostatic
potential of differently substituted triazines in combination with
steric effects of the substituent at position 3 (Figure S1).We also studied the influence of various
solvents on the alkylation
reaction. Anhydrous toluene was found superior over other solvents
with the minor N2 isomer being formed in 15% yield
using the methyl triflate and in only 10% using the ethyl triflate.
We found that the two N-alkylated isomers can be
separated by reversed phase column chromatography. However, the N2 isomer does not interfere with the subsequent DCA step
and can be easily removed during purification of the final cycloaddition
product. Therefore, we used the crude mixture of the triazinium isomers
in all subsequent experiments. Under the optimized conditions, we
next prepared a series of triazinium triflates 2a-o-Me(Et) in excellent yields (Scheme ).
Scheme 2
Scope of Triazinium Compounds
Standard
conditions: triazine 1a–1o (2 mmol), triflate
(2.4 mmol), anhydrous toluene
(20 mL), 0 °C to RT, under argon. Note: all compounds are triflate
salts.
Scope of Triazinium Compounds
Standard
conditions: triazine 1a–1o (2 mmol), triflate
(2.4 mmol), anhydrous toluene
(20 mL), 0 °C to RT, under argon. Note: all compounds are triflate
salts.The alkylation is basically quantitative,
and the formed triazinium
salt simply precipitates from the reaction mixture in most cases.
The reaction can be conveniently performed on a larger scale (hundreds
of milligrams), and the 1-alkyltriazinium triflates are surprisingly
stable when stored in the crystalline form and even in solution (Figure S2).With the set of triaziniums
in hand, we proceeded to optimize the
1,3-dipolar cycloaddition reaction using DMAD as the dipolarophile
and 3-phenyltriazinium methyl triflates 2a-Me and 2b-Me as model substrates. We experimented with different
bases, solvents, temperatures, and orders of reagent addition. Unfortunately,
all these efforts led only to decomposition of the starting materials
and formation of the cycloaddition product in less than 10% yield
in the best case.In contrast to these initial results, we found
that the cycloaddition
of compounds bearing additional substituents at position 5 is viable.
In this case, the reaction with DMAD performed in tetrahydrofuran
(THF) in the presence of N,N-diisopropylethylamine
(DIPEA) afforded the desired cycloaddition products 3d-m-H(Me) in good to very good yields (up to 84%). The reaction proceeded
smoothly, and a wide range of triaziniums bearing various aryl substituents
at position 5 were tolerated (Scheme ). In general, cycloadditions of ethyl triazinium ylides
gave higher yields when compared to the methylated analogues. The
final pyrrolotriazines form in the reaction as the fully oxidized
products especially from the methyl triaziniums. If this was not the
case, the dihydro intermediates were converted to the oxidized products
by simply opening the reaction flask to the air. By following the
reaction progress on high-performance liquid chromatography mass spectrometry,
we observed that a small portion of the triazinium compounds undergoes
dequarternization at the nitrogen atom to yield the starting triazine.
Although the exact mechanism remains unclear, similar dealkylation
of N-alkyl triazinium salts has been observed previously.[37] Interestingly, the pyrrolotriazines are fluorescent
compounds when irradiated at 365 nm using a standard handheld UV lamp.
This property could be potentially exploited in preparation of new
fluorophores based on this heterocyclic core.
Scheme 3
1,3-Dipolar Cycloaddition
of Triazinium Ylides with DMAD
Standard conditions:
triazinium
(0.5 mmol), DMAD (2 mmol), THF (10 mL), DIPEA (1.5 mmol), 0 °C
to RT, 5 h.
1,3-Dipolar Cycloaddition
of Triazinium Ylides with DMAD
Standard conditions:
triazinium
(0.5 mmol), DMAD (2 mmol), THF (10 mL), DIPEA (1.5 mmol), 0 °C
to RT, 5 h.Encouraged by these results, we
decided to explore the possibility
of using other dipolarophiles in the reaction (Scheme ).
Scheme 4
Scope of Dipolarophiles
Hence, reaction of 1-methyl-5-phenyl-1,2,4-triazinium
triflate 2g-Me with methyl propiolate performed in THF
using DIPEA
as the base yielded after optimization the desired pyrrolotriazine 4g-H as a single regioisomer in 38% yield. The observed formation
of the single regioisomer in the reaction is substantiated by the
5.0 kcal/mol lower energy of the corresponding transition state as
evident from density functional theory (DFT) calculations (Figure S3). Even though the cycloaddition was
in this case complicated by the competing reaction of the DIPEA base
with the electron-poor triple bond,[38] this
approach opens the possibility to generate additional pyrrolotriazines
in a regioselective manner.To further expand the scope of dipolarophiles,
we performed the
reaction with acrylonitrile, N-ethylmaleimide, and N-propargylmaleimide. The reaction with acrylonitrile yielded
two diastereomers of a single regioisomer 5g-H in a 2
to 1 ratio and in 54% overall yield. The reaction with maleimide proceeded
smoothly and afforded two diastereomeric products 6g-H in an 8 to 1 ratio and 88% overall yield. Based on DFT calculations,
the transition state structure leading to the major product has lower
calculated energy by 0.9 kcal/mol (Figure S4). Interestingly, only the minor isomer slowly oxidizes to the corresponding
pyrrolotriazine. Cycloaddition experiments with N-propargylmaleimide and triaziniums 2g-Me and 2j-Me confirmed the diastereoselectivity of the transformation
and yielded pyrrolotriazines 7g-H and 7j-H in 59% (significant dequarternization) and 95% overall yield, respectively.Finally, to demonstrate the possibility of further derivatization
of the pyrrolotriazine scaffold, we performed pilot coupling experiments
with cycloadduct 3i-Me (Scheme ). The thiomethyl substituent at position
3 was successfully utilized in the Liebeskind–Srogl cross-coupling
reaction with phenylboronic acid under standard conditions. The corresponding
3-phenyl pyrrolotriazine isolated in 54% yield was used in the next
Suzuki–Miyaura cross-coupling reaction, which gave the desired
heterocyclic product 8i-Me in excellent 90% isolated
yield.
In conclusion, we show
that 1,3-dipolar cycloadditions of electron-poor
dipolarophiles with triazinium ylides generated in situ from 1-alkyl-1,2,4-triazinium
salts provide a facile access to various pyrrolo[2,1-f][1,2,4]triazines in a single step. The reaction gives differently
substituted pyrrolotriazines in good yields, and the resulting compounds
can be further elaborated by selective cross-coupling reactions. Our
experimental data complemented by DFT calculations demonstrate that
the reactions can be regio- and diastereoselective. We believe that
the presented methodology will provide an efficient synthetic route
to medicinally relevant pyrrolotriazines from readily available starting
materials.
Authors: M Raymond V Finlay; Mark Anderton; Andrew Bailey; Scott Boyd; Joanna Brookfield; Ceri Cairnduff; Mark Charles; Anne Cheasty; Susan E Critchlow; Janet Culshaw; Tennyson Ekwuru; Ian Hollingsworth; Neil Jones; Fred Leroux; Mairi Littleson; Hollie McCarron; Jennifer McKelvie; Lorraine Mooney; J Willem M Nissink; David Perkins; Steve Powell; Mar Jimenez Quesada; Piotr Raubo; Verity Sabin; James Smith; Peter D Smith; Andrew Stark; Attilla Ting; Peng Wang; Zena Wilson; Jon J Winter-Holt; J Matthew Wood; Gail L Wrigley; Guoqing Yu; Peng Zhang Journal: J Med Chem Date: 2019-07-16 Impact factor: 7.446
Authors: Tho Thieu; Joseph A Sclafani; Daniel V Levy; Andrew McLean; Henry J Breslin; Gregory R Ott; Roger P Bakale; Bruce D Dorsey Journal: Org Lett Date: 2011-07-26 Impact factor: 6.005
Authors: Edward M Tyndall; Alistair G Draffan; Barbara Frey; Brett Pool; Rosliana Halim; Saba Jahangiri; Silas Bond; Veronika Wirth; Angela Luttick; Danielle Tilmanis; Jesse Thomas; Kate Porter; Simon P Tucker Journal: Bioorg Med Chem Lett Date: 2014-12-30 Impact factor: 2.823
Authors: Gretchen M Schroeder; Xiao-Tao Chen; David K Williams; David S Nirschl; Zhen-Wei Cai; Donna Wei; John S Tokarski; Yongmi An; John Sack; Zhong Chen; Tram Huynh; Wayne Vaccaro; Michael Poss; Barri Wautlet; Johnni Gullo-Brown; Kristen Kellar; Veeraswamy Manne; John T Hunt; Tai W Wong; Louis J Lombardo; Joseph Fargnoli; Robert M Borzilleri Journal: Bioorg Med Chem Lett Date: 2008-02-07 Impact factor: 2.823
Authors: Zhen-Wei Cai; Donna Wei; Robert M Borzilleri; Ligang Qian; Amrita Kamath; Steven Mortillo; Barri Wautlet; Benjamin J Henley; Robert Jeyaseelan; John Tokarski; John T Hunt; Rajeev S Bhide; Joseph Fargnoli; Louis J Lombardo Journal: Bioorg Med Chem Lett Date: 2008-01-09 Impact factor: 2.823